Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 13/20 | 0.69 |
| ▸ | CTSS | P25774 | 4/20 | 0.65 |
| ▸ | CTSL | P07711 | 4/20 | 0.65 |
| ▸ | CTSB | P07858 | 2/20 | 0.65 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13611959 | 0.88 | CTSK (0.74) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL14609392 | 0.88 | CTSK (0.74) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL3978105 | 0.88 | CTSK (0.74) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL27493720 | 0.87 | CTSK (0.69) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL27493719 | 0.87 | CTSK (0.69) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL7492293 | 0.86 | ALDH1A1 (0.65) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL7492287 | 0.86 | ALDH1A1 (0.65) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL7499936 | 0.86 | ALDH1A1 (0.65) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL30065121 | 0.86 | CTSK (0.58) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL1823902 | 0.86 | CTSK (0.76) | CTSKCTSSCTSLCTSBCAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230001000-A1 | COMPOSITION AND METHOD FOR HIP1-TARGETING INHIBITOR COMPOUNDS | UTAH VALLEY UNIVERSITY | 2023-01-05 | — | — | US | claimed |
| US-12605456-B2 | Composition and method for HIP1-targeting inhibitor compounds | UTAH VALLEY UNIVERSITY (US) | 2026-04-21 | — | — | US | disclosed |
| US-20230001000-A1 | COMPOSITION AND METHOD FOR HIP1-TARGETING INHIBITOR COMPOUNDS | UTAH VALLEY UNIVERSITY | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605456-B2 | Composition and method for HIP1-targeting inhibitor compounds | CHAMP1, WHR1, OTUB1 | CTSK 2012/4885CTSS 1656/4885CTSL 1271/4885 |
| US-20230001000-A1 | COMPOSITION AND METHOD FOR HIP1-TARGETING INHIBITOR COMPOUNDS | HIPK1, WHR1, HIPK3 | CTSK 3586/4885CTSS 3385/4885CTSL 3809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.